Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DexCom, Inc.

Market Cap 27.49B 23.71B 21.8B 20.52B 38.56B 2,594B 38.88B 258B 101B 1,273B 103B 101B 4,404B P/E 2026 *
29.1x
P/E 2027 * 24.4x
Enterprise Value 27.12B 23.39B 21.51B 20.24B 38.04B 2,559B 38.36B 255B 99.23B 1,256B 102B 99.6B 4,345B EV / Sales 2026 *
5.19x
EV / Sales 2027 * 4.5x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day-2.64%
1 week-4.73%
Current month-3.40%
1 month+15.58%
3 months+5.81%
6 months+8.33%
Current year+7.32%
1 week 70.9
Extreme 70.9
76.25
1 month 64.46
Extreme 64.465
78.91
Current year 56.72
Extreme 56.72
78.91
1 year 54.11
Extreme 54.11
89.98
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 2025-12-31
Director of Finance/CFO 46 2021-03-18
Chief Tech/Sci/R&D Officer - 2024-04-30
Director TitleAgeSince
Chairman 68 2018-07-29
Director/Board Member 67 2009-11-19
Director/Board Member 47 2025-12-31
Date Insider Type Main position Quantity % Market Cap.
Jun. 03Sell

Executive/Senior Manager

-4,911 0.0013%
May. 27Free

Director

5,575 0.0014%
May. 27Free

Director

5,565 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-2.64%-4.73%-12.95%-45.25% 28.23B
-2.34%-0.75%-33.10%-16.67% 158B
-3.91%-2.63%-9.32%-12.35% 104B
+2.86%+10.31%+65.03%+62.10% 56.43B
-1.55%-1.48%-5.49%+51.41% 54.76B
-2.45%-4.18%-16.67%-45.25% 40B
-1.81%-0.33% - - 31.36B
-1.82%-2.22%+48.39%-10.62% 23.28B
+0.07%-0.80%-14.62%-4.51% 20.41B
-3.44%-4.18%-15.89%-6.65% 20.13B
Average -1.75%-1.47%+0.60%-3.09% 53.68B
Weighted average by Cap. -1.99%-0.97%-6.63%-2.30%

Financials

2026 *2027 *
Net sales 5.22B 4.51B 4.14B 3.9B 7.33B 493B 7.39B 49.11B 19.12B 242B 19.61B 19.19B 837B 5.83B 5.03B 4.62B 4.35B 8.18B 550B 8.25B 54.8B 21.33B 270B 21.88B 21.41B 934B
Net income 963M 830M 763M 719M 1.35B 90.84B 1.36B 9.05B 3.52B 44.58B 3.61B 3.54B 154B 1.16B 999M 918M 864M 1.62B 109B 1.64B 10.88B 4.24B 53.62B 4.35B 4.25B 186B
Net Debt -370M -319M -293M -276M -518M -34.87B -523M -3.47B -1.35B -17.11B -1.39B -1.36B -59.21B -1.25B -1.08B -990M -931M -1.75B -118B -1.76B -11.73B -4.57B -57.78B -4.68B -4.58B -200B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
26-06-17 71.23 $ -2.64% 4,430,997
26-06-16 73.16 $ -1.43% 3,058,343
26-06-15 74.22 $ -1.53% 5,388,470
26-06-12 75.37 $ +0.16% 4,773,926
26-06-11 75.25 $ +0.64% 6,607,417
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
71.23USD
Average target price
85.21USD
Spread / Average Target
+19.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!